biotranslation ltd
biotranslation ltd Company Information
Company Number
10061676
Next Accounts
Dec 2025
Shareholders
jonathan peter waterman-smith
Group Structure
View All
Industry
Management consultancy activities (other than financial management)
Registered Address
38 varndean gardens, brighton, BN1 6WL
Website
biotranslation.wordpress.combiotranslation ltd Estimated Valuation
Pomanda estimates the enterprise value of BIOTRANSLATION LTD at £14.4k based on a Turnover of £41.8k and 0.35x industry multiple (adjusted for size and gross margin).
biotranslation ltd Estimated Valuation
Pomanda estimates the enterprise value of BIOTRANSLATION LTD at £0 based on an EBITDA of £-24.1k and a 2.97x industry multiple (adjusted for size and gross margin).
biotranslation ltd Estimated Valuation
Pomanda estimates the enterprise value of BIOTRANSLATION LTD at £0 based on Net Assets of £-3.8k and 2.61x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biotranslation Ltd Overview
Biotranslation Ltd is a live company located in brighton, BN1 6WL with a Companies House number of 10061676. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in March 2016, it's largest shareholder is jonathan peter waterman-smith with a 100% stake. Biotranslation Ltd is a young, micro sized company, Pomanda has estimated its turnover at £41.8k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Biotranslation Ltd Health Check
Pomanda's financial health check has awarded Biotranslation Ltd a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 9 areas for improvement. Company Health Check FAQs
0 Strong
1 Regular
9 Weak
Size
annual sales of £41.8k, make it smaller than the average company (£429.5k)
- Biotranslation Ltd
£429.5k - Industry AVG
Growth
3 year (CAGR) sales growth of -19%, show it is growing at a slower rate (10.5%)
- Biotranslation Ltd
10.5% - Industry AVG
Production
with a gross margin of 25.4%, this company has a higher cost of product (58.3%)
- Biotranslation Ltd
58.3% - Industry AVG
Profitability
an operating margin of -57.5% make it less profitable than the average company (8.4%)
- Biotranslation Ltd
8.4% - Industry AVG
Employees
with 1 employees, this is below the industry average (5)
- Biotranslation Ltd
5 - Industry AVG
Pay Structure
on an average salary of £49.1k, the company has an equivalent pay structure (£49.1k)
- Biotranslation Ltd
£49.1k - Industry AVG
Efficiency
resulting in sales per employee of £41.8k, this is less efficient (£116.8k)
- Biotranslation Ltd
£116.8k - Industry AVG
Debtor Days
it gets paid by customers after 175 days, this is later than average (63 days)
- Biotranslation Ltd
63 days - Industry AVG
Creditor Days
its suppliers are paid after 9 days, this is quicker than average (25 days)
- Biotranslation Ltd
25 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Biotranslation Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Biotranslation Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 118.7%, this is a higher level of debt than the average (52.7%)
118.7% - Biotranslation Ltd
52.7% - Industry AVG
BIOTRANSLATION LTD financials
Biotranslation Ltd's latest turnover from March 2024 is estimated at £41.8 thousand and the company has net assets of -£3.8 thousand. According to their latest financial statements, we estimate that Biotranslation Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Other Income Or Grants | ||||||||
| Cost Of Sales | ||||||||
| Gross Profit | ||||||||
| Admin Expenses | ||||||||
| Operating Profit | ||||||||
| Interest Payable | ||||||||
| Interest Receivable | ||||||||
| Pre-Tax Profit | ||||||||
| Tax | ||||||||
| Profit After Tax | ||||||||
| Dividends Paid | ||||||||
| Retained Profit | ||||||||
| Employee Costs | ||||||||
| Number Of Employees | 2 | 2 | 2 | |||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | ||||||||
| Intangible Assets | ||||||||
| Investments & Other | ||||||||
| Debtors (Due After 1 year) | ||||||||
| Total Fixed Assets | ||||||||
| Stock & work in progress | ||||||||
| Trade Debtors | 20,143 | 50,178 | 37,130 | 32,877 | 22,090 | 25,569 | 59,428 | |
| Group Debtors | ||||||||
| Misc Debtors | ||||||||
| Cash | ||||||||
| misc current assets | ||||||||
| total current assets | 20,143 | 50,178 | 37,130 | 32,877 | 22,090 | 25,569 | 59,428 | |
| total assets | 20,143 | 50,178 | 37,130 | 32,877 | 22,090 | 25,569 | 59,428 | |
| Bank overdraft | ||||||||
| Bank loan | ||||||||
| Trade Creditors | 820 | 12,313 | 21,776 | 13,556 | 19,301 | 21,738 | 32,026 | |
| Group/Directors Accounts | ||||||||
| other short term finances | ||||||||
| hp & lease commitments | ||||||||
| other current liabilities | ||||||||
| total current liabilities | 820 | 12,313 | 21,776 | 13,556 | 19,301 | 21,738 | 32,026 | |
| loans | ||||||||
| hp & lease commitments | ||||||||
| Accruals and Deferred Income | ||||||||
| other liabilities | 23,087 | 17,575 | ||||||
| provisions | ||||||||
| total long term liabilities | 23,087 | 17,575 | ||||||
| total liabilities | 23,907 | 29,888 | 21,776 | 13,556 | 19,301 | 21,738 | 32,026 | |
| net assets | -3,764 | 20,290 | 15,354 | 19,321 | 2,789 | 3,831 | 27,402 | |
| total shareholders funds | -3,764 | 20,290 | 15,354 | 19,321 | 2,789 | 3,831 | 27,402 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | ||||||||
| Depreciation | ||||||||
| Amortisation | ||||||||
| Tax | ||||||||
| Stock | ||||||||
| Debtors | -30,035 | 13,048 | 4,253 | 10,787 | -3,479 | -33,859 | 59,428 | |
| Creditors | -11,493 | -9,463 | 8,220 | -5,745 | -2,437 | -10,288 | 32,026 | |
| Accruals and Deferred Income | ||||||||
| Deferred Taxes & Provisions | ||||||||
| Cash flow from operations | ||||||||
| Investing Activities | ||||||||
| capital expenditure | ||||||||
| Change in Investments | ||||||||
| cash flow from investments | ||||||||
| Financing Activities | ||||||||
| Bank loans | ||||||||
| Group/Directors Accounts | ||||||||
| Other Short Term Loans | ||||||||
| Long term loans | ||||||||
| Hire Purchase and Lease Commitments | ||||||||
| other long term liabilities | 5,512 | 17,575 | ||||||
| share issue | ||||||||
| interest | ||||||||
| cash flow from financing | ||||||||
| cash and cash equivalents | ||||||||
| cash | ||||||||
| overdraft | ||||||||
| change in cash |
biotranslation ltd Credit Report and Business Information
Biotranslation Ltd Competitor Analysis
Perform a competitor analysis for biotranslation ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in BN1 area or any other competitors across 12 key performance metrics.
biotranslation ltd Ownership
BIOTRANSLATION LTD group structure
Biotranslation Ltd has no subsidiary companies.
Ultimate parent company
BIOTRANSLATION LTD
10061676
biotranslation ltd directors
Biotranslation Ltd currently has 2 directors. The longest serving directors include Mr Jonathan Waterman-Smith (Mar 2016) and Dr Li Poh (Jan 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Jonathan Waterman-Smith | England | 66 years | Mar 2016 | - | Director |
| Dr Li Poh | England | 53 years | Jan 2018 | - | Director |
P&L
March 2024turnover
41.8k
-58%
operating profit
-24.1k
0%
gross margin
25.4%
-2.78%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
-3.8k
-1.19%
total assets
20.1k
-0.6%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
biotranslation ltd company details
company number
10061676
Type
Private limited with Share Capital
industry
70229 - Management consultancy activities (other than financial management)
incorporation date
March 2016
age
9
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
38 varndean gardens, brighton, BN1 6WL
Bank
-
Legal Advisor
-
biotranslation ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to biotranslation ltd.
biotranslation ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOTRANSLATION LTD. This can take several minutes, an email will notify you when this has completed.
biotranslation ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
